Vertex Pharmaceuticals, Inc. (VRTX)
436.95
-13.46
(-2.99%)
USD |
NASDAQ |
May 15, 16:00
437.70
+0.75
(+0.17%)
After-Hours: 20:00
Vertex Pharmaceuticals Shareholders Equity (Quarterly) : 19.36B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.19B |
| Biogen, Inc. | 18.65B |
| Gilead Sciences, Inc. | 23.52B |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
| Moderna, Inc. | 7.408B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.48B |
| Total Liabilities (Quarterly) | 7.122B |
| Debt to Equity Ratio | 0.1026 |
| Current Ratio | 3.023 |
| Net Debt Paydown Yield | -0.04% |